Vanguard Group’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $31.9M | Buy |
8,467,400
+1,627,495
| +24% | +$3.16M | ﹤0.01% | 2408 |
|
|
2025
Q3 | $11M | Buy |
6,839,905
+185,106
| +3% | +$330K | ﹤0.01% | 2933 |
|
|
2025
Q2 | $14.6M | Buy |
6,654,799
+3,815,481
| +134% | +$5.86M | ﹤0.01% | 2713 |
|
|
2025
Q1 | $3.07M | Buy |
2,839,318
+546,461
| +24% | +$649K | ﹤0.01% | 3342 |
|
|
2024
Q4 | $2.38M | Hold |
2,292,857
| – | – | ﹤0.01% | 3508 |
|
|
2024
Q3 | $2.87M | Buy |
2,292,857
+506,523
| +28% | +$619K | ﹤0.01% | 3448 |
|
|
2024
Q2 | $2.13M | Buy |
1,786,334
+273,099
| +18% | +$372K | ﹤0.01% | 3538 |
|
|
2024
Q1 | $1.53M | Buy |
1,513,235
+365,911
| +32% | +$307K | ﹤0.01% | 3676 |
|
|
2023
Q4 | $1.22M | Buy |
1,147,324
+110,418
| +11% | +$119K | ﹤0.01% | 3767 |
|
|
2023
Q3 | $1.7M | Buy |
1,036,906
+90,198
| +10% | +$142K | ﹤0.01% | 3644 |
|
|
2023
Q2 | $1.49M | Buy |
946,708
+49,796
| +6% | +$80K | ﹤0.01% | 3766 |
|
|
2023
Q1 | $1.28M | Buy |
896,912
+40,828
| +5% | +$101K | ﹤0.01% | 3839 |
|
|
2022
Q4 | $2.02M | Buy |
856,084
+25,965
| +3% | +$72.8K | ﹤0.01% | 3648 |
|
|
2022
Q3 | $1.68M | Hold |
830,119
| – | – | ﹤0.01% | 3815 |
|
|
2022
Q2 | $1.85M | Buy |
830,119
+173,200
| +26% | +$508K | ﹤0.01% | 3837 |
|
|
2022
Q1 | $4.39M | Buy |
656,919
+2,357
| +0.4% | +$13.8K | ﹤0.01% | 3597 |
|
|
2021
Q4 | $3.62M | Buy |
654,562
+3,279
| +0.5% | +$24.8K | ﹤0.01% | 3787 |
|
|
2021
Q3 | $5.97M | Buy |
651,283
+32,749
| +5% | +$304K | ﹤0.01% | 3539 |
|
|
2021
Q2 | $6.87M | Buy |
618,534
+148,681
| +32% | +$1.45M | ﹤0.01% | 3405 |
|
|
2021
Q1 | $4.01M | Sell |
469,853
-107,211
| -19% | -$877K | ﹤0.01% | 3639 |
|
|
2020
Q4 | $3.35M | Buy |
577,064
+441,956
| +327% | +$1.77M | ﹤0.01% | 3511 |
|
|
2020
Q3 | $358K | Sell |
135,108
-24,000
| -15% | -$65.7K | ﹤0.01% | 3866 |
|
|
2020
Q2 | $466K | Hold |
159,108
| – | – | ﹤0.01% | 3784 |
|
|
2020
Q1 | $275K | Sell |
159,108
-690
| -0.4% | -$1.78K | ﹤0.01% | 3808 |
|
|
2019
Q4 | $687K | Sell |
159,798
-263
| -0.2% | -$1.42K | ﹤0.01% | 3729 |
|
|
2019
Q3 | $968K | Buy |
160,061
+150,534
| +1,580% | +$1.11M | ﹤0.01% | 3662 |
|
|
2019
Q2 | $54K | Sell |
9,527
-5,219
| -35% | -$185K | ﹤0.01% | 4102 |
|
|
2019
Q1 | $752K | Buy |
14,746
+2,228
| +18% | +$155K | ﹤0.01% | 3695 |
|
|
2018
Q4 | $770K | Buy |
12,518
+5,175
| +70% | +$401K | ﹤0.01% | 3637 |
|
|
2018
Q3 | $448K | Buy |
7,343
+3,546
| +93% | +$245K | ﹤0.01% | 3871 |
|
|
2018
Q2 | $649K | Buy |
3,797
+2,069
| +120% | +$567K | ﹤0.01% | 3784 |
|
|
2018
Q1 | $298K | Buy |
1,728
+1,115
| +182% | +$318K | ﹤0.01% | 3892 |
|
|
2017
Q4 | $241K | Sell |
613
-161
| -21% | -$77.8K | ﹤0.01% | 3896 |
|
|
2017
Q3 | $410K | Sell |
774
-114
| -13% | -$75.2K | ﹤0.01% | 3788 |
|
|
2017
Q2 | $774K | Buy |
888
+9
| +1% | +$7.83K | ﹤0.01% | 3633 |
|
|
2017
Q1 | $804K | Buy |
879
+746
| +561% | +$1.24M | ﹤0.01% | 3638 |
|
|
2016
Q4 | $386K | Buy |
+133
| New | +$773K | ﹤0.01% | 3782 |
|
Other funds holding SLS
N
DI